Innovation for
Unmet
Medical
Needs
Global Leader
of Network
R&D
Clinical & non-clinical
pipeline with
Global
standard
-
company
Until the early 2000s, the big pharmaceutical companies had extended their business scope in order to cover most of the R&D phases from the discovery of new drug targets to development of late-stage clinical trials. See More
-
Business philosophy
Qurient has introduced ‘Network R&D’ model, a Unique and development model aimiing to achieve ‘capital efficient innovation’. See More
-
Pipeline
There are three therapeutic area that Qurient focus on – anti cancer, anti inflammation and antibiotics. Qurient can handle these diverse pipeline because qurient makes alliance with many research organization and has expertise to manage R&D full value-chain... See More
-
IR/PR
Dear Qurient shareholders
Qurient would like to share brief updates on current progress made on its portfolio programs. See More
-
Key Information
-
Useful Information
-
Get in Touch